Home » Topics » Regulatory » Patents

Patents
RSS

GABA-A alpha5 subunit-selective inverse agonists from Merck useful for Alzheimer's disease

March 12, 1999

Kynurenine 3-monooxygenase inhibitors for neurodegenerative disorders

March 12, 1999

Novel class of GABA-A receptor ligands for cognitive disorders from Merck

March 11, 1999

Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc.

March 11, 1999

Inhibitors of metallo-beta-lactamases discovered at SmithKline Beecham

March 11, 1999

Novel neuraminidase inhibitors described by U. of Florida

March 11, 1999

Heterocyclic factor Xa inhibitors disclosed by Zeneca

March 11, 1999

Improved non-nucleoside HIV-1 RT inhibitors in development at Boehringer Ingelheim

March 11, 1999

Plant-derived topoisomerase II inhibitors patented by Meiji Milk

March 10, 1999

Yamanouchi describes novel anticoagulants

March 10, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...